Prolonged Overnight Oximetry in Obstructive Sleep Apnoea
Launched by SOMERSET NHS FOUNDATION TRUST · Feb 26, 2020
Trial Information
Current as of May 10, 2025
Unknown status
Keywords
ClinConnect Summary
Obstructive sleep apnoea (OSA) is a common condition, effecting an estimated 1.5 million people in the UK and it is believed up to 80% of them may be undiagnosed \[1\]. During sleep the muscles supporting the upper airway tend to relax and the throat narrows. In patients with OSA the narrowing leads to collapse and pauses in breathing. These pauses in breathing are accompanied by a decrease in arterial oxygen saturation and to overcome the airway collapse the body responds by producing a surge in the sympathetic nervous system. This has the effect of stimulating the pharyngeal muscles to re...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Willing to participate and give informed consent to participate
- • Male or Female aged 18 years or older
- • Referral letter or request to sleep service reports an Epworth Sleepiness Score of greater than 9 or reason for the referral is 'excessive daytime sleepiness'
- Exclusion Criteria:
- • Significant cardiovascular or respiratory co-morbidities
- • Suspected hypoventilation or sleep disordered breathing
- • Previously used Non-invasive ventilation
- • In the Investigators opinion an alternative diagnostic test should be offered as first line e.g. referral information suggests an inpatient sleep study is required.
About Somerset Nhs Foundation Trust
Somerset NHS Foundation Trust is a leading healthcare organization dedicated to delivering high-quality medical services and advancing clinical research in the region. As a sponsor of clinical trials, the Trust focuses on fostering innovative treatments and improving patient outcomes through rigorous scientific investigation. With a commitment to ethical standards and patient safety, Somerset NHS Foundation Trust collaborates with diverse stakeholders to facilitate cutting-edge research across various medical disciplines, ensuring that findings translate into effective healthcare solutions for the community it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Justin Pepperell
Principal Investigator
Somerset NHS Foundation Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials